34. Martindale. The Complete Drug Reference (Book with CD-ROM), 34th Edition by Sean C. Sweetman.35. Boukes FS, Van der Burgh JJ, Nijman FC et al. NHG-Standaard Bacteriële Huidinfecties. Huisarts Wet1998;41:427-37.http://nhg.artsennet.nl/upload/104/standaarden/M68/start.htm36. Laube S, Farrell AM. Bacterial skin infections in the elderly: diagnosis and treatment. Drugs Aging2002;19:331-42.37. Morris A. Cellulitis and erysipelas. BMJ Clinical evidence [online] 2007 [cited june].38. Prodigy guidance. Celullitis. Nov 2005. www.cks.library.nhs.uk/39. CREST. Guidelines on the management of cellulitis in adults. June 2005 www.crestni.org.uk40. Von den Driesch P. Candidiasis. Evidence Based Dermatology. BMJ Books. April 2003, p. 490-500.41. Dekker JH, Boeke AJP, Gercama AJ et al. NHG-standaard Fluor vaginalis. Huis Wet 2005;48(9):459-66.42. Répertoire commenté des médicaments 2007. Centre belge d’iformation pharmacothérapeutique.www.cbip.be43. De Kock CA, Duyvendak RJP, Jaspar AHJ et al. NHG-Standaard dermatomycosen.http://nhg.artsennet.nl/standaarden/M64/start.htm44. Dermatomycosen. Farmacotherapeutisch Kompas 2007. http://www.fk.cvz.nl/45. Crawford F. Athlete’s foot. BMJ Clinical evidence [online] 2007 [cited june].46. Prodigy guidance. Fungal (dermatophyte) skin infections. www.cks.library.nhs.uk/47. Crawford F, Ferrari J. Fungal nail infections. BMJ Clinical evidence [online] 2007 [cited june].48. Prodigy guidance. Fungal and candidal nail infection. Prodigy www.cks.library.nhs.uk/49. Amabile CM, Spencer AP. Keeping your patient with heart failure safe: a review of potentially dangerousmedications. Arch Intern Med 2004;164:709-20.50. Szepietowski JC, Reich A, Garlowska E, et al. Factors Influencing Coexistence of Toenail OnychomycosisWith Tinea Pedis and Other Dermatomycosis: A Survey of 2761 Patients. Arch Dermatol 2006;142:279-84.51. Johnstone P, Strong M. Scabies. BMJ Clinical evidence [online] 2007 [cited june].52. Prodigy Guidance – Scabies. February 2004. www.cks.library.nhs.uk/53. Lapeere H. Aanpak van schurft in rust- en verzorgingstehuizen. Tijdschr Geneeskd 2007;63:235-7.54. Vanderwee K, Grypdonck M & Defloor T. Non-blanchable erythema as an indicator for the need forpressure ulcer prevention: a randomized-controlled trial. J Clin Nurs 2007;16,325-335.55. Nixon J, Cranny G, Iglesias C e.a. Randomised, controlled trial of alternating pressure mattressescompared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressurerelieving support surfaces) trial. BMJ 2006;332:1413-5.56. Cullum N, Petherick E. Pressure ulcers. BMJ Clinical evidence [online] 2007 [cited june].57. The management of pressure ulcers in primary and secondary care. A clinical practice guideline. RoyalCollege of Nursing 2005.58. Chel VGM, Germs PH, Van der Wal J et al. NHG-Standaard decubitus.http://nhg.artsennet.nl/standaarden/M70/start.htm59. Moore ZEH, Cowman S. Wound cleansing for pressure ulcers. The Cochrane Database of SystematicReviews 2005, Issue 4. Art No.: CD004983.pub2. DOI:10.1002/14651858. CD04983.pub2.60. Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers.The Cochrane Database of Systematic Reviews 2006, Issue 1. Art.No.: CD005082.pub2.DOI:10.1002/14651858.CD005082.pub2.61. Schweitzer BPM, Doorenbosch J, Glotzbach R et al. NHG-Standaard Ulcus cruris venosum.http://nhg.artsennet.nl/standaarden/M16/start.htm62. Nelson EA, Cullum N, Jones J. Venous leg ulcers. Clin Evid 2005;14:2408-24.63. Richtlijn Diagnostiek en behandeling van het ulcus cruris venosum. Nederlandse Vereniging voor<strong>Dermatologie</strong> en Venerologie, 2005.64. Palfreyman SJ, Nelson EA, Lochiel R, Michaels JA. Dressings for healing venous leg ulcers. CochraneDatabase of Systematic Reviews 2006, Issue 3. Art. No.: CD001103. DOI:10.1002/14651858.CD001103.pub2.65. Nelson EA, Cullum N, Jones J. Venous leg ulcers. BMJ Clinical evidence [online] 2007 [cited june].66. Nelson EA, Bradley MD. Dressings and topical agents for arterial leg ulcers. Cochrane Database ofSystematic Reviews 2007, Issue 1. Art. No.: CD001836. DOI: 10.1002/14651858.CD001836.pub2.67. Hailey D, Jacobs P, Perry DC e.a. Adjunctive Hyperbaric Oxygen Therapy for Diabetic Foot Ulcer: AnEconomic Analysis [Technology overview no 25]. Ottawa: Canadian Agency for Drugs and Technology inHealth; 2007. http://www.cadth.ca/438 <strong>Dermatologie</strong>
68. Finnish Medical Society Duodecim. Psoriasis . In: EBM Guidelines. Evidence-Based Medicine HelsinkiFinland.69. Naldi L, Rzany B. Chronic plaque psoriasis. BMJ Clinical evidence [online] 2007 [cited june].70. Anonymous. Cancers cutanés après puvathérapie. La Revue Prescrire 2005;261:353.71. Anonymous. Psoriasis des adultes. Des rémissions, mais pas de traitement curatif. La Revue Prescrire2005;25:751-62.72. Anonymous. Analogues de la vitamine D en cas de psoriasis. Folia Pharmacotherapeutica 2003;30:7-8.www.bcip.be73. Van Hecke E. Calcipotriol voor chronische plaque psoriasis. Minerva (Huisarts Nu) 2002;32:378-80.http://www.minerva-ebm.be/articles/nl/pdf_2002/7-2002_kort_calcipotriol.pdf74. Lantinga H, Ek JW, Nijman FC et al. NHG-Standaard Psoriasis (tweede herziening).http://nhg.artsennet.nl/upload/104/standaarden/M39/start.htm75. Bruner CR, Feldman SR, Ventrapragada M et al. A systematic review of adverse effects associated withtopical treatments for psoriasis. Dermatol Online J 2003;9:2.76. Afifi T, de Gannes G, Huang C et al. Topical therapies for psoriasis: evidence-based review. Can FamPhysician 2005;51:519-25.77. NHS Scotland. Calcipotriol and betamethasone dipropionate ointment. Scottisch Medicines ConsortiumNo 09/02. www.scottishmedicines.org.uk<strong>Dermatologie</strong> 439
Change language